| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Shapiro Aron serves as a Director at KPRX. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $11K at current prices.
The biggest single holding is KPRX (~$11K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 3,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | KPRX Kiora Pharmaceuticals Inc | Director | Buy | 3,000 | $3.60 | $10,800.00 | New | +0.6% | -22.6% |